Gaps in Adhering to Pap Testing Recommendations and Related Barriers in a Sample of Young Adults in the US.

Tanvi Sapra, Katelyn F Romm, Daisy Le, Carla J Berg
Author Information
  1. Tanvi Sapra: Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
  2. Katelyn F Romm: TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  3. Daisy Le: School of Nursing, George Washington University, Washington, DC, USA.
  4. Carla J Berg: George Washington Cancer Center, George Washington University, 800 22nd Street NW, #7000C, Washington, DC, 20052, USA. carlaberg@gwu.edu. ORCID

Abstract

Given ongoing gaps in adherence to Pap testing recommendations, this study examined: 1) adherence to Pap test screening recommendations; and 2) barriers to Pap test screening among those who were nonadherent, using constructs from the Andersen model. We analyzed Spring 2022 survey data among 541 US young adults who reported having a cervix (n = 541; mean age = 27.73, 42.1% heterosexual, 57.9% sexual minority, 86.0% woman, 3.7% transgender man, 68.2% White, 31.8% racial/ethnic minority). Multivariable logistic regression examined sociodemographic correlates of nonadherence to Pap testing recommendations (i.e., no Pap testing in the past 3 years). Among those who were nonadherent, barriers to Pap testing were assessed. 68.6% (n = 371) were defined as adherent and 31.4% (n = 170) nonadherent. Multivariable regression findings indicated significant differences by race/ethnicity such that Asians (vs. Whites) were more likely to be nonadherent (OR = 2.41, CI = 1.11, 3.70, p = .021); no other differences in relation to race/ethnicity or sexual/gender identity were found. The most commonly reported barriers were: "I have not gotten around to it" (42.9%), "getting a Pap test is just not a priority for me" (30.6%), "fear/worry" (28.2%), "dislike/don't like having procedures done" (27.1%), "my healthcare provider has never mentioned it" (21.2%), "haven't had sex so I don't consider myself at high risk" (20.6%), and "COVID-19 pandemic prevented me" (15.3%). Pap testing is underutilized among young adults in the US, particularly Asians. Multilevel interventions must address barriers within the healthcare system (e.g., provider recommendation), external environment (e.g., societal factors), and individual realm (e.g., perceptions).

Keywords

References

  1. J Community Health. 2019 Jun;44(3):525-533 [PMID: 30915676]
  2. Cancer Causes Control. 2022 Apr;33(4):559-582 [PMID: 34984592]
  3. J Adv Nurs. 2011 Feb;67(2):428-37 [PMID: 20946564]
  4. J Health Soc Behav. 1995 Mar;36(1):1-10 [PMID: 7738325]
  5. Prev Med. 2022 Jun;159:107055 [PMID: 35460715]
  6. J Am Coll Radiol. 2019 Apr;16(4 Pt B):607-620 [PMID: 30947895]
  7. Curr Probl Cancer. 2022 Oct;46(5):100858 [PMID: 35422312]
  8. Oncol Nurs Forum. 2020 Jan 1;47(1):44-55 [PMID: 31845916]
  9. Am J Public Health. 2015 Feb;105(2):e98-e109 [PMID: 25521898]
  10. Health Serv Res. 1998 Aug;33(3 Pt 1):571-96 [PMID: 9685123]
  11. J Obstet Gynecol Neonatal Nurs. 2018 Jan;47(1):52-63 [PMID: 29144960]
  12. Prev Med Rep. 2021 Nov 27;24:101652 [PMID: 34976700]
  13. J Med Internet Res. 2021 Jul 30;23(7):e26759 [PMID: 34328423]
  14. J Natl Med Assoc. 2020 Jun;112(3):300-307 [PMID: 32291069]
  15. J Health Care Poor Underserved. 2015 May;26(2 Suppl):36-52 [PMID: 25981087]
  16. J Cancer Educ. 2023 Apr;38(2):682-690 [PMID: 35585475]
  17. LGBT Health. 2017 Aug;4(4):304-309 [PMID: 28422558]
  18. Tob Regul Sci. 2021 Jan;7(1):59-75 [PMID: 34368404]
  19. JMIR Mhealth Uhealth. 2019 Jun 6;7(6):e13256 [PMID: 31199340]
  20. JAMA Netw Open. 2022 Jan 4;5(1):e2143582 [PMID: 35040970]
  21. Prev Med. 2021 Mar;144:106400 [PMID: 33388330]
  22. Lancet Oncol. 2019 Mar;20(3):319-321 [PMID: 30795952]
  23. Can Fam Physician. 2019 Jan;65(1):e30-e37 [PMID: 30674526]
  24. Asia Pac J Public Health. 2016 Mar;28(2):107-33 [PMID: 26769982]
  25. J Immigr Minor Health. 2016 Dec;18(6):1404-1412 [PMID: 26424729]
  26. PLoS One. 2017 Feb 24;12(2):e0172548 [PMID: 28234949]
  27. MMWR Morb Mortal Wkly Rep. 2017 Mar 03;66(8):201-206 [PMID: 28253225]
  28. Health Expect. 2023 Feb;26(1):172-182 [PMID: 36444391]
  29. Acta Cytol. 2016;60(6):518-526 [PMID: 27825171]
  30. J Community Health. 2019 Feb;44(1):1-11 [PMID: 29936641]
  31. BMC Public Health. 2015 Jan 29;15:28 [PMID: 25630218]

Grants

  1. R01 CA278229/NCI NIH HHS
  2. K01 CA276624/NCI NIH HHS
  3. P30 CA225520/NCI NIH HHS
  4. D43 ES030927/NIEHS NIH HHS
  5. L60 DA056995/NIDA NIH HHS
  6. R01 DA054751/NIDA NIH HHS
  7. D43 TW012456/FIC NIH HHS
  8. R01 CA215155/NCI NIH HHS
  9. R01 TW010664/FIC NIH HHS
  10. U54 MD015946/NIMHD NIH HHS
  11. R01CA215155-01A1/NCI NIH HHS
  12. R25 DA054015/NIDA NIH HHS
  13. R01 CA275066/NCI NIH HHS
  14. L60 CA264786/NCI NIH HHS
  15. R01 CA239178/NCI NIH HHS
  16. R21 CA261884/NCI NIH HHS

MeSH Term

Female
Young Adult
Humans
Male
Papanicolaou Test
Ethnicity
Pandemics
Gender Identity
Minority Groups
Uterine Cervical Neoplasms
Vaginal Smears
Early Detection of Cancer

Word Cloud

Created with Highcharts 10.0.0PaptestingbarriersnonadherenterecommendationstestscreeningamongUSadults2%6%gadherenceyoungreported421%9%minority36831Multivariableregressiondifferencesrace/ethnicityAsiansit"me"healthcareproviderYounghealthGivenongoinggapsstudyexamined:12usingconstructsAndersenmodelanalyzedSpring2022surveydata541cervixn = 541meanage = 2773heterosexual57sexual860%woman7%transgendermanWhite8%racial/ethniclogisticexaminedsociodemographiccorrelatesnonadherenceipast3 yearsAmongassessedn = 371definedadherent4%n = 170findingsindicatedsignificantvsWhiteslikelyOR = 241CI = 11170p = 021relationsexual/genderidentityfoundcommonlywere:"Igottenaround"gettingjustpriority30"fear/worry"28"dislike/don'tlikeproceduresdone"27"mynevermentioned21"haven'tsexconsiderhighrisk"20"COVID-19pandemicprevented153%underutilizedparticularlyMultilevelinterventionsmustaddresswithinsystemrecommendationexternalenvironmentsocietalfactorsindividualrealmperceptionsGapsAdheringTestingRecommendationsRelatedBarriersSampleAdultsCancerCervicalcancerReproductiveWomen’s

Similar Articles

Cited By